Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hydroxymethylglutaryl-CoA reductase (NADPH) | 0.1517 | 1 | 1 |
Mycobacterium ulcerans | hydroxymethylglutaryl-coenzyme a (HMG-CoA) reductase | 0.1517 | 1 | 1 |
Leishmania major | 3-hydroxy-3-methylglutaryl-CoA reductase | 0.1517 | 1 | 1 |
Echinococcus multilocularis | protein dispatched 1 | 0.0625 | 0.4047 | 0.4034 |
Trypanosoma cruzi | 3-hydroxy-3-methylglutaryl-CoA reductase, putative | 0.1517 | 1 | 1 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0021 | 0.0022 | 0.0022 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0021 | 0.0022 | 0.0022 |
Loa Loa (eye worm) | abnormal chemotaxis protein 14 | 0.0625 | 0.4047 | 0.4047 |
Loa Loa (eye worm) | hypothetical protein | 0.1517 | 1 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0068 | 0.0337 | 0.0316 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0068 | 0.0337 | 1 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0021 | 0.0022 | 0.5 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0065 | 0.0312 | 0.0312 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0778 | 0.507 | 0.5059 |
Mycobacterium tuberculosis | Probable short-chain type dehydrogenase/reductase | 0.0065 | 0.0312 | 0.92 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0068 | 0.0337 | 0.0316 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0068 | 0.0337 | 0.0337 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.0712 | 0.4628 | 1 |
Trypanosoma brucei | 3-hydroxy-3-methylglutaryl-CoA reductase, putative | 0.1517 | 1 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0068 | 0.0337 | 0.0337 |
Echinococcus granulosus | sterol regulatory element binding protein | 0.0625 | 0.4047 | 0.4034 |
Echinococcus multilocularis | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0065 | 0.0312 | 0.0291 |
Echinococcus granulosus | Protein patched homolog 1 | 0.0625 | 0.4047 | 0.4034 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0021 | 0.0022 | 0.0022 |
Brugia malayi | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0065 | 0.0312 | 0.0312 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0068 | 0.0337 | 0.0316 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0778 | 0.507 | 0.5059 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0021 | 0.0022 | 0.0022 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0021 | 0.0022 | 0.5 |
Schistosoma mansoni | niemann-pick C1 (NPC1) | 0.0625 | 0.4047 | 0.4034 |
Trypanosoma cruzi | 3-hydroxy-3-methylglutaryl-CoA reductase | 0.1517 | 1 | 1 |
Echinococcus granulosus | Niemann Pick C1 protein | 0.0625 | 0.4047 | 0.4034 |
Loa Loa (eye worm) | 3-hydroxyacyl-CoA dehydrogenase type II | 0.006 | 0.0283 | 0.0283 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0021 | 0.0022 | 0.0022 |
Leishmania major | 3-oxoacyl-(acyl-carrier protein) reductase, putative | 0.0065 | 0.0312 | 0.0312 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.0625 | 0.4047 | 0.4034 |
Echinococcus multilocularis | protein patched | 0.0625 | 0.4047 | 0.4034 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0068 | 0.0337 | 1 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.0712 | 0.4628 | 1 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0021 | 0.0022 | 0.0022 |
Echinococcus granulosus | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0065 | 0.0312 | 0.0291 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0021 | 0.0022 | 0.5 |
Echinococcus multilocularis | sterol regulatory element binding protein | 0.0625 | 0.4047 | 0.4034 |
Schistosoma mansoni | 3-hydroxyacyl-CoA dehydrogenase | 0.0065 | 0.0312 | 0.0291 |
Giardia lamblia | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0.0712 | 0.4628 | 1 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0778 | 0.507 | 0.5059 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0065 | 0.0312 | 0.0312 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0021 | 0.0022 | 0.0022 |
Echinococcus multilocularis | hydroxymethylglutaryl coenzyme A reductase | 0.1517 | 1 | 1 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0021 | 0.0022 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0625 | 0.4047 | 0.4047 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0068 | 0.0337 | 0.0337 |
Schistosoma mansoni | patched 1 | 0.0625 | 0.4047 | 0.4034 |
Echinococcus granulosus | hydroxymethylglutaryl coenzyme A reductase | 0.1517 | 1 | 1 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0021 | 0.0022 | 0.5 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0068 | 0.0337 | 0.0337 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0625 | 0.4047 | 0.8738 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.0712 | 0.4628 | 1 |
Brugia malayi | CHE-14 protein | 0.0625 | 0.4047 | 0.4047 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0068 | 0.0337 | 0.0316 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | Antifungal activity against Candida albicans ATCC 1600 after 48 hrs | ChEMBL. | 19902967 | |
Activity (functional) | Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs | ChEMBL. | 19902967 | |
Activity (functional) | Antifungal activity against Saccharomyces sake ATCC 26421 after 48 hrs | ChEMBL. | 19902967 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.